Baozhi Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Baozhi Yang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bo Peng
National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University
1 shared publication Li Cao
Key Laboratory of Molecular Neurobiology, Ministry of Education, Navy Military Medical University
1 shared publication- Niewen Hu
National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University
1 shared publication - Pei Ouyang
National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University
1 shared publication Shuai Gao
National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University
1 shared publication- Xiaoyu Li
National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 15
In vivo virus-free lineage tracing and live imaging reveal that NeuroD1 does not reprogram microglia into neurons
In situ glia-to-neuron conversion induced by a single transcription factor is a promising regenerative strategy for treating central nervous system injuries and neurodegenerative diseases. Previous studies reported that NeuroD1 can induce microglia-to-neuron cross-lineage conversion and improve recovery after brain injury. However, these findings remain controversial. To examine the ability of NeuroD1 in inducing microglia-to-neuron conversion, we employed virus-free genetic lineage tracing systems in mice to specifically induce NeuroD1 expression in microglia and track the cell fate of NeuroD1-expressing cells at multiple timepoints. Meanwhile, we longitudinally monitored NeuroD1-expressing microglia via two-photon imaging and characterized their transcriptional profile by single-cell RNA sequencing. All observations across these methods revealed that NeuroD1-expressing cells retained their microglia identity and cannot convert into neurons, under either physiological or injury conditions. Instead, sustained expression of NeuroD1 induced microglial apoptosis in vivo. Collectively, our findings provide strong evidence that NeuroD1 is not sufficient to induce microglia-to-neuron conversion. This study further highlights the importance of rigorous lineage tracing and cell fate mapping strategies for validating in situ glia-to-neuron conversion.
- 16 October 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 15
Open AccessIn vivo virus-free lineage tracing and live imaging reveal that NeuroD1 does not reprogram microglia into neurons
In situ glia-to-neuron conversion induced by a single transcription factor is a promising regenerative strategy for treating central nervous system injuries and neurodegenerative diseases. Previous studies reported that NeuroD1 can induce microglia-to-neuron cross-lineage conversion and improve recovery after brain injury. However, these findings remain controversial. To examine the ability of NeuroD1 in inducing microglia-to-neuron conversion, we employed virus-free genetic lineage tracing systems in mice to specifically induce NeuroD1 expression in microglia and track the cell fate of NeuroD1-expressing cells at multiple timepoints. Meanwhile, we longitudinally monitored NeuroD1-expressing microglia via two-photon imaging and characterized their transcriptional profile by single-cell RNA sequencing. All observations across these methods revealed that NeuroD1-expressing cells retained their microglia identity and cannot convert into neurons, under either physiological or injury conditions. Instead, sustained expression of NeuroD1 induced microglial apoptosis in vivo. Collectively, our findings provide strong evidence that NeuroD1 is not sufficient to induce microglia-to-neuron conversion. This study further highlights the importance of rigorous lineage tracing and cell fate mapping strategies for validating in situ glia-to-neuron conversion.